Isn't It Time We Stop Counting the Number of Drugs to Define Polypharmacy in This New Era of Deprescribing and What Related Outcomes Should Be Measured?
Year: 2018
Type: editorial
Authors: Joseph T. Hanlon, Emily R. Hajjar
Language: English
Subfield: Geriatrics and Gerontology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2805690535
